These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. CNOT7/hCAF1 is involved in ICAM-1 and IL-8 regulation by tristetraprolin. Shi JX; Li JS; Hu R; Shi Y; Su X; Li Q; Zhang F Cell Signal; 2014 Nov; 26(11):2390-6. PubMed ID: 25038453 [TBL] [Abstract][Full Text] [Related]
23. Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway. Peng CL; Guo W; Ji T; Ren T; Yang Y; Li DS; Qu HY; Li X; Tang S; Yan TQ; Tang XD Cancer Biol Ther; 2009 Sep; 8(18):1729-36. PubMed ID: 19633425 [TBL] [Abstract][Full Text] [Related]
24. IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence. Datta S; Novotny M; Pavicic PG; Zhao C; Herjan T; Hartupee J; Hamilton T J Immunol; 2010 Feb; 184(3):1484-91. PubMed ID: 20042592 [TBL] [Abstract][Full Text] [Related]
25. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Suswam E; Li Y; Zhang X; Gillespie GY; Li X; Shacka JJ; Lu L; Zheng L; King PH Cancer Res; 2008 Feb; 68(3):674-82. PubMed ID: 18245466 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812 [TBL] [Abstract][Full Text] [Related]
27. Tristetraprolin regulates IL-8 mRNA stability in cystic fibrosis lung epithelial cells. Balakathiresan NS; Bhattacharyya S; Gutti U; Long RP; Jozwik C; Huang W; Srivastava M; Pollard HB; Biswas R Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L1012-8. PubMed ID: 19363120 [TBL] [Abstract][Full Text] [Related]
28. The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cells. Panka DJ; Wang W; Atkins MB; Mier JW Cancer Res; 2006 Feb; 66(3):1611-9. PubMed ID: 16452220 [TBL] [Abstract][Full Text] [Related]
29. Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. Augustine CK; Toshimitsu H; Jung SH; Zipfel PA; Yoo JS; Yoshimoto Y; Selim MA; Burchette J; Beasley GM; McMahon N; Padussis J; Pruitt SK; Ali-Osman F; Tyler DS Mol Cancer Ther; 2010 Jul; 9(7):2090-101. PubMed ID: 20571072 [TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Clement SL; Scheckel C; Stoecklin G; Lykke-Andersen J Mol Cell Biol; 2011 Jan; 31(2):256-66. PubMed ID: 21078877 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E. Lee MH; Lee SE; Kim DW; Ryu MJ; Kim SJ; Kim SJ; Kim YK; Park JH; Kweon GR; Kim JM; Lee JU; De Falco V; Jo YS; Shong M J Clin Endocrinol Metab; 2011 Jan; 96(1):E19-30. PubMed ID: 20926530 [TBL] [Abstract][Full Text] [Related]
32. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA. Kim CW; Kim HK; Vo MT; Lee HH; Kim HJ; Min YJ; Cho WJ; Park JW Biochem Biophys Res Commun; 2010 Sep; 400(1):46-52. PubMed ID: 20691152 [TBL] [Abstract][Full Text] [Related]
33. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA. Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523 [TBL] [Abstract][Full Text] [Related]
34. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Zhang Z; Guo M; Li Y; Shen M; Kong D; Shao J; Ding H; Tan S; Chen A; Zhang F; Zheng S Autophagy; 2020 Aug; 16(8):1482-1505. PubMed ID: 31679460 [TBL] [Abstract][Full Text] [Related]
35. The dual PI3K/mTOR inhibitor PI-103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib-treated melanoma cells. López-Fauqued M; Gil R; Grueso J; Hernandez-Losa J; Pujol A; Moliné T; Recio JA Int J Cancer; 2010 Apr; 126(7):1549-61. PubMed ID: 19810100 [TBL] [Abstract][Full Text] [Related]
36. Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer. Huang L; Yu Z; Zhang Z; Ma W; Song S; Huang G Sci Rep; 2016 Mar; 6():22449. PubMed ID: 26926077 [TBL] [Abstract][Full Text] [Related]
38. Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability. Chen F; Shyu AB; Shneider BL Hepatology; 2011 Oct; 54(4):1371-8. PubMed ID: 21688286 [TBL] [Abstract][Full Text] [Related]
39. Tristetraprolin down-regulates IL-17 through mRNA destabilization. Lee HH; Yoon NA; Vo MT; Kim CW; Woo JM; Cha HJ; Cho YW; Lee BJ; Cho WJ; Park JW FEBS Lett; 2012 Jan; 586(1):41-6. PubMed ID: 22138182 [TBL] [Abstract][Full Text] [Related]
40. 3'UTR AU-Rich Elements (AREs) and the RNA-Binding Protein Tristetraprolin (TTP) Are Not Required for the LPS-Mediated Destabilization of Phospholipase-Cβ-2 mRNA in Murine Macrophages. Shukla S; Elson G; Blackshear PJ; Lutz CS; Leibovich SJ Inflammation; 2017 Apr; 40(2):645-656. PubMed ID: 28124257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]